Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Uxin (UXIN) Revenue (2017 - 2025)

Uxin filings provide 9 years of Revenue readings, the most recent being $168.9 million for Q4 2025.

  • On a quarterly basis, Revenue rose 106.57% to $168.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $330.4 million, a 11.34% increase, with the full-year FY2025 number at $463.3 million, up 86.38% from a year prior.
  • Revenue hit $168.9 million in Q4 2025 for Uxin, up from $122853.5 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $79.2 billion in Q4 2021 to a low of $94.96 in Q2 2022.
  • Median Revenue over the past 5 years was $43.8 million (2021), compared with a mean of $6.7 billion.
  • Biggest five-year swings in Revenue: surged 162657419.35% in 2021 and later tumbled 100.0% in 2022.
  • Uxin's Revenue stood at $79.2 billion in 2021, then tumbled by 100.0% to $68216.0 in 2022, then decreased by 15.25% to $57815.0 in 2023, then soared by 141318.32% to $81.8 million in 2024, then skyrocketed by 106.57% to $168.9 million in 2025.
  • The last three reported values for Revenue were $168.9 million (Q4 2025), $122853.5 (Q3 2025), and $91.9 million (Q2 2025) per Business Quant data.